Health Ministry Approves Public Insurance Coverage for iPS-derived Medicine Amchepry for Parkinson’s Japan’s Health Ministry approved public insurance coverage on May 14, 2026 for Sumitomo Pharma’s iPS-derived medicine Amchepry for …
The Tokyo Tribune @2020 – All Rights Reserved.